Vir Biotechnology, Inc. (VIR) Financials

VIR Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 1.0 billion 212.8 million
Dec. 31, 2025 1.0 billion 237.5 million
Sept. 30, 2025 1.0 billion 223.4 million
June 30, 2025 1.2 billion 245.1 million

VIR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -132.8 million 12.1 million
Dec. 31, 2025 -21.4 million 22.6 million
Sept. 30, 2025 -167.9 million 11.4 million
June 30, 2025 -122.8 million 12.5 million

VIR Net Income

No data available :(

VIR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 472.4 million 86.6 million 95.6 million
Dec. 31, 2025 462.9 million 89.1 million 89.1 million
Sept. 30, 2025 506.5 million - 100.2 million
June 30, 2025 606.0 million - 102.2 million

VIR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 147.4 million
Dec. 31, 2025 139.2 million
Sept. 30, 2025 138.9 million
June 30, 2025 138.4 million

VIR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 390000 108.9 million 23.3 million -
Dec. 31, 2025 4.5 million 88.3 million 23.6 million -
Sept. 30, 2025 317000 151.5 million 22.2 million -
June 30, 2025 2.5 million 97.5 million 22.3 million -

VIR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 -29000 2.8 million
Dec. 31, 2025 64.1 million -366.6 million
Sept. 30, 2025 240000 151.5 million
June 30, 2025 1.2 million 97.5 million

VIR Revenue by Segment
Graph available only for paid members. Upgrade to see it.

VIR

Price: $8.61

52 week price:
4.16
11.66

Earnings Per Share: -3.13 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 703157

Market Capitalization: 1.5 billion

Links: